Chemoinformaics analysis of 4-Methoxy-3-[(quinolin-8-yloxy)methyl]benzaldehyde
| Molecular Weight | 293.322 | nRot | 5 |
| Heavy Atom Molecular Weight | 278.202 | nRig | 18 |
| Exact Molecular Weight | 293.105 | nRing | 3 |
| Solubility: LogS | -3.842 | nHRing | 1 |
| Solubility: LogP | 2.654 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 43.5679 |
| nHD | 0 | BPOL | 20.5281 |
| QED | 0.674 |
| Synth | 2.012 |
| Natural Product Likeliness | -0.666 |
| NR-PPAR-gamma | 0.677 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.796 |
| MDCK | 0.000023 |
| BBB | 0.797 |
| PPB | 0.975721 |
| VDSS | 1.215 |
| FU | 0.0223974 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.785 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.366 |
| CYP2c9-inh | 0.76 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.117 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.534 |
| CYP3a4-sub | 0.355 |
| CL | 6.19 |
| T12 | 0.565 |
| hERG | 0.339 |
| Ames | 0.914 |
| ROA | 0.039 |
| SkinSen | 0.191 |
| Carcinogencity | 0.83 |
| EI | 0.558 |
| Respiratory | 0.868 |
| NR-Aromatase | 0.64 |
| Antiviral | Yes |
| Prediction | 0.838735 |